The speed of change: Towards a discontinuity theory of immunity?

Nature Reviews Immunology

Volumn 13, Issue 10, 2013, Pages 764-769

  Pradeu, Thomas ^a   Jaeger, Sébastien ^b   Vivier, Eric ^b,c  

^a SORBONNE UNIVERSITÉ   (France)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN;

ADAPTIVE IMMUNITY; CELL INTERACTION; EFFECTOR CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MACROPHAGE ACTIVATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; THEORETICAL STUDY;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, VIRAL; AUTOANTIGENS; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; MACROPHAGES; MODELS, IMMUNOLOGICAL; SELF TOLERANCE; TIME FACTORS;

EID: 84886783887     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3521     Document Type: Review

References (67)

1. Craver, C. F. in Blackwell Guide to the Philosophy of Science (eds Machamer, P. K. and Silberstein, M.), 55-79 (Blackwell, 2001).
2. Greenspan, N. S. Conceptualizing immune responsiveness. Nature Immunol. 8, 5-7 (2007). (Pubitemid 46242348)
3. Vivier, E. et al. Innate or adaptive immunity? The example of natural killer cells. Science 331, 44-49 (2011).
4. Orr, M. T. & Lanier, L. L. Natural killer cell education and tolerance. Cell 142, 847-856 (2010).
5. Gasser, S. & Raulet, D. H. Activation and self-tolerance of natural killer cells. Immunol. Rev. 214, 130-142 (2006). (Pubitemid 44707907)
6. Kärre, K., Ljunggren, H. G., Piontek, G. & Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675-678 (1986). (Pubitemid 16119452)
7. Höglund, P. et al. Recognition of β2-microglobulin-negative (β2m-) T-cell blasts by natural killer cells from normal but not from β2m-mice: nonresponsiveness controlled by β2m-bone marrow in chimeric mice. Proc. Natl Acad. Sci. USA 88, 10332-10336 (1991). (Pubitemid 21915829)
8. Liao, N. S., Bix, M., Zijlstra, M., Jaenisch, R. & Raulet, D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253, 199-202 (1991). (Pubitemid 21917142)
9. Joncker, N. T., Shifrin, N., Delebecque, F. & Raulet, D. H. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J. Exp. Med. 207, 2065-2072 (2010).
10. Elliott, J. M., Wahle, J. A. & Yokoyama, W. M. MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J. Exp. Med. 207, 2073-2079 (2010).
11. Savill, J., Dransfield, I., Gregory, C. & Haslett, C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nature Rev. Immunol. 2, 965-975 (2002). (Pubitemid 37323217)
12. Stuart, L. M. & Ezekowitz, R. A. Phagocytosis and comparative innate immunity: learning on the fly. Nature Rev. Immunol. 8, 131-141 (2008). (Pubitemid 351161303)
13. Green, D. R., Ferguson, T., Zitvogel, L. & Kroemer, G. Immunogenic and tolerogenic cell death. Nature Rev. Immunol. 9, 353-363 (2009).
14. Jeannin, P., Jaillon, S. & Delneste, Y. Pattern recognition receptors in the immune response against dying cells. Curr. Opin. Immunol. 20, 530-537 (2008).
15. Ahrens, S. et al. F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity 36, 635-645 (2012).
16. Foster, S. L., Hargreaves, D. C. & Medzhitov, R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447, 972-978 (2007). (Pubitemid 46975746)
17. null cells. Proc. Natl Acad. Sci. USA 104, 13744-13749 (2007). (Pubitemid 350003391)
18. Ramsdell, F. & Fowlkes, B. J. Maintenance of in vivo tolerance by persistence of antigen. Science 257, 1130-1134 (1992).
19. Goodnow, C. C. et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676-682 (1988).
20. Virgin, H. W., Wherry, E. J. & Ahmed, R. Redefining chronic viral infection. Cell 138, 30-50 (2009).
21. Utzschneider, D. T. et al. T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion. Nature Immunol. 14, 603-610 (2013).
22. Turchinovich, G. & Hayday, A. C. Skint-1 identifies a common molecular mechanism for the development of interferon-γ-secreting versus interleukin-17-secreting γδ T cells. Immunity 35, 59-68 (2011).
23. Grossman, Z. & Paul, W. E. Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. Proc. Natl Acad. Sci. USA 89, 10365-10369 (1992).
24. Grossman, Z., Min, B., Meier-Schellersheim, M. & Paul, W. E. Concomitant regulation of T-cell activation and homeostasis. Nature Rev. Immunol. 4, 387-395 (2004). (Pubitemid 38649281)
25. Schenten, D. & Medzhitov, R. The control of adaptive immune responses by the innate immune system. Adv. Immunol. 109, 87-124 (2011).
26. Shankaran, V. et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107-1111 (2001). (Pubitemid 32391043)
27. Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960-1964 (2006). (Pubitemid 44498003)
28. Smyth, M. J., Dunn, G. P. & Schreiber, R. D. in Advances in Immunology (ed. Allison, J. P.) 1-50 (Elsevier, 2006).
29. Raulet, D. H. & Guerra, N. Oncogenic stress sensed by the immune system: role of natural killer cell receptors, Nature Rev. Immunol. 9, 568-580 (2009).
30. Kraman, M. et al. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-α. Science 330, 827-830 (2010).
31. Pardoll, D. Does the immune system see tumors as foreign or self? Annu. Rev. Immunol. 21, 807-839 (2003). (Pubitemid 37174548)
32. + T cells is hampered by persistent systemic antigen, but full functional capacity is regained in an antigen-free environment. J. Immunol. 172, 6074-6079 (2004). (Pubitemid 38621209)
33. Drake, C. G., Jaffee, E. & Pardoll, D. M. Mechanisms of immune evasion by tumors. Adv. Immunol. 90, 51-81 (2006). (Pubitemid 43765799)
34. Pradeu, T. & Carosella, E. D. On the definition of a criterion of immunogenicity. Proc. Natl Acad. Sci. USA 103, 17858-17861 (2006) (Pubitemid 44852250)
35. Burnet, F. M. Cancer: a biological approach. Br. Med. J. 1, 1-7 (1957).
36. Thomas, L. in Cellular and humoral aspects of the hypersensitive states (Lawrence, 1959).
37. Burnet, F. M. Immunological surveillance (Pergamon, 1970).
38. Zinkernagel, R. M. & Doherty, P. C. Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytes choriomeningitis. Nature 251, 547-548 (1974).
39. Houghton, A. N. Cancer antigens: immune recognition of self and altered self. J. Exp. Med. 180, 1-4 (1994). (Pubitemid 24181047)
40. Laughlin, S. B. The role of sensory adaptation in the retina. J. Exp. Biol. 146, 39-62 (1989). (Pubitemid 19255646)
41. Wark, B., Lundstrom, B. N. & Fairhall, A. Sensory adaptation. Curr. Opin. Neurobiol. 17, 423-429 (2007). (Pubitemid 47531945)
42. Bray, D., Levin, M. D. & Morton-Firth, C. J. Receptor clustering as a cellular mechanism to control sensitivity. Nature 393, 85-88 (1998). (Pubitemid 28240260)
43. Henrickson, S. E. et al. T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation. Nature Immunol. 9, 282-291 (2008). (Pubitemid 351267325)
44. Apostolou, I. & von Boehmer, H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199, 1401-1408 (2004). (Pubitemid 38685731)
45. Kyes, S., Horrocks, P. & Newbold, C. Antigenic variation at the infected red cell surface in malaria. Annu. Rev. Microbiol. 55, 673-707 (2001). (Pubitemid 32978120)
46. MacGregor, P., Szöor, B., Savill, N. J. & Matthews, K. R. Trypanosomal immune evasion, chronicity and transmission: an elegant balancing act. Nature Rev. Micro 10, 431-438 (2012).
47. Ndung'u, T. & Weiss, R. A. On HIV diversity. AIDS 26, 1255-1260 (2012).
48. Csikász-Nagy, A. & Soyer, O. S. Adaptive dynamics with a single two-state protein. J. R. Soc. Interface 5, S41-S47 (2008). (Pubitemid 351915289)
49. Daëron, M., Jaeger, S., Du Pasquier, L. & Vivier, E. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol. Rev. 224, 11-43 (2008).
50. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003). (Pubitemid 36222930)
51. + regulatory T cells. Nature Immunol. 4, 330-336 (2003). (Pubitemid 36432314)
52. + T regulatory cells. Nature Immunol. 4, 337-342 (2003). (Pubitemid 36432315)
53. Kuhn, T. S. The structure of scientific revolutions (Univ. of Chicago Press, 1962).
54. Matzinger, P. The danger model: a renewed sense of self. Science 296, 301-305 (2002). (Pubitemid 34303674)
55. Hooper, L. V., Littman, D. R. & Macpherson, A. J. Interactions between the microbiota and the immune system. Science 336, 1268-1273 (2012).
56. Lathrop, S. K. et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 478, 250-254 (2011).
57. Belkaid, Y. & Oldenhove, G. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 29, 362-371 (2008).
58. Shklovskaya, E. et al. Langerhans cells are precommitted to immune tolerance induction. Proc. Natl Acad. Sci. USA 108, 18049-18054 (2011).
59. Carrat, F. & Flahault, A. Influenza vaccine: The challenge of antigenic drift. Vaccine 25, 6852-6862 (2007). (Pubitemid 47398929)
60. Pradeu, T. The limits of the self: immunology and biological identity 131-183 (Oxford Univ. Press, 2012).
61. Du Pasquier, L. & Bernard, C. C. A. Active suppression of the allogeneic histocompatibility reactions during the metamorphosis of the clawed toad Xenopus. Differentiation 16, 131-183 (1980).
62. + T cell sequestration, dysfunction and deletion. Nature Med. 19, 465-472 (2013).
63. Burks, A. W. et al. Oral immunotherapy for treatment of egg allergy in children. N. Engl. J. Med. 367, 233-243 (2012).
64. Bernard, C. Experimental medicine. (original text published in 1865). (Transaction, 1999).
65. Popper, K. R. Logik der forschung: zur erkenntnistheorie der modernen naturwissenschaft. (J. Springer, 1935).
66. National Research Council. The role of theory in advancing 21st-century biology: catalyzing transformative research. [online] http://www.nap.edu/ openbook.php?record-id=12026) (The National Academies 2008).
67. Guia, S. et al. Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance. Sci. Signal. 4, ra21 (2011).